The pathogenesis of thyroid cancer often begins with a single genetic alteration in either the mitogen-activated protein kinase (MAPK) pathway or phosphatidylinositol 3-kinase (PI3K) pathway, leading to uncontrolled cell growth, proliferation, and apoptosis. This evidence concerns the gene PIK3CA and thyroid gland carcinoma.